Search research articles
Contact Us
Filters
Showing results (31-40 of 213) with videos related to
Page
of 22
Sort By:
Science (New York, N.Y.)
|
October 7, 2021
Gut bacteria enable prostate cancer growth
John A McCulloch, Giorgio Trinchieri
Immunological Reviews
|
November 18, 2004
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
Alain P Vicari, Giorgio Trinchieri
Cancer Discovery
|
August 4, 2025
A New Dimension in Tumor Heterogeneity: Intratumoral Bacteria Impact Multifocal Hepatocellular Carcinoma Development
Amiran K Dzutsev, Giorgio Trinchieri
The Journal of Experimental Medicine
|
August 17, 2005
Production of type I interferons: plasmacytoid dendritic cells and beyond
Carine Asselin-Paturel, Giorgio Trinchieri
Nature Immunology
|
September 20, 2012
The price of immunity
Romina S Goldszmid, Giorgio Trinchieri
Annual Review of Immunology
|
December 5, 2025
Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting
Hassane M Zarour, Giorgio Trinchieri
Journal for Immunotherapy of Cancer
|
April 3, 2025
Unlocking the power of the microbiome for successful cancer immunotherapy
Maria A Clavijo-Salomon, Giorgio Trinchieri
Immunity
|
November 15, 2003
The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses
Giorgio Trinchieri, Stefan Pflanz, Robert A Kastelein
Seminars in Cancer Biology
|
April 3, 2002
Tumour escape from immune surveillance through dendritic cell inactivation
Alain P Vicari, Christophe Caux, Giorgio Trinchieri
Cell Host & Microbe
|
March 18, 2014
Host immune response to infection and cancer: unexpected commonalities
Romina S Goldszmid, Amiran Dzutsev, Giorgio Trinchieri
Page
of 22
Search research articles
Search
Showing results (31-40 of 213) with videos related to
Sort By:
Page
of 22
Science (New York, N.Y.)
|
October 7, 2021
Gut bacteria enable prostate cancer growth
John A McCulloch, Giorgio Trinchieri
Immunological Reviews
|
November 18, 2004
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
Alain P Vicari, Giorgio Trinchieri
Cancer Discovery
|
August 4, 2025
A New Dimension in Tumor Heterogeneity: Intratumoral Bacteria Impact Multifocal Hepatocellular Carcinoma Development
Amiran K Dzutsev, Giorgio Trinchieri
The Journal of Experimental Medicine
|
August 17, 2005
Production of type I interferons: plasmacytoid dendritic cells and beyond
Carine Asselin-Paturel, Giorgio Trinchieri
Nature Immunology
|
September 20, 2012
The price of immunity
Romina S Goldszmid, Giorgio Trinchieri
Annual Review of Immunology
|
December 5, 2025
Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting
Hassane M Zarour, Giorgio Trinchieri
Journal for Immunotherapy of Cancer
|
April 3, 2025
Unlocking the power of the microbiome for successful cancer immunotherapy
Maria A Clavijo-Salomon, Giorgio Trinchieri
Immunity
|
November 15, 2003
The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses
Giorgio Trinchieri, Stefan Pflanz, Robert A Kastelein
Seminars in Cancer Biology
|
April 3, 2002
Tumour escape from immune surveillance through dendritic cell inactivation
Alain P Vicari, Christophe Caux, Giorgio Trinchieri
Cell Host & Microbe
|
March 18, 2014
Host immune response to infection and cancer: unexpected commonalities
Romina S Goldszmid, Amiran Dzutsev, Giorgio Trinchieri
Page
of 22